Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finel

Showing results (161-170 of 248) with videos related to

Pageof 25
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2011
Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferasesStacie M Bratton, Carrie M Mosher, Farid Khallouki, et al.
Pharmacogenetics and Genomics|February 16, 2007
Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6Mika Kurkela, Anne-Sisko Patana, Peter I Mackenzie, et al.
International Journal of Biological Macromolecules|March 20, 2021
A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitorsQi-Hang Zhou, Wei-Wei Qin, Moshe Finel, et al.
The Journal of Biological Chemistry|November 19, 2002
Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzymeMika Kurkela, J Arturo García-Horsman, Leena Luukkanen, et al.
Bioorganic & Medicinal Chemistry|May 4, 2015
Exploring the structure-activity relationships of ABCC2 modulators using a screening approachGloria Wissel, Pavel Kudryavtsev, Leo Ghemtio, et al.
Planta Medica|February 9, 2019
Metabolism of Scoparone in Experimental Animals and HumansRisto O Juvonen, Filip Novák, Eleni Emmanouilidou, et al.
Journal of Medicinal Chemistry|May 4, 2007
Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivativesIngo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 11, 2017
Identification and characterization of human UDP-glucuronosyltransferases responsible for xanthotoxol glucuronidationGuiyuan He, Johanna Troberg, Xia Lv, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 1, 2019
In vitro glucuronidation of 7-hydroxycoumarin derivatives in intestine and liver microsomes of Beagle dogsRisto O Juvonen, Aki T Heikkinen, Olli Kärkkäinen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2011
Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoformsLiangliang Zhu, Guangbo Ge, Hongbo Zhang, et al.
Pageof 25

Showing results (161-170 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2011
Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferasesStacie M Bratton, Carrie M Mosher, Farid Khallouki, et al.
Pharmacogenetics and Genomics|February 16, 2007
Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6Mika Kurkela, Anne-Sisko Patana, Peter I Mackenzie, et al.
International Journal of Biological Macromolecules|March 20, 2021
A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitorsQi-Hang Zhou, Wei-Wei Qin, Moshe Finel, et al.
The Journal of Biological Chemistry|November 19, 2002
Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzymeMika Kurkela, J Arturo García-Horsman, Leena Luukkanen, et al.
Bioorganic & Medicinal Chemistry|May 4, 2015
Exploring the structure-activity relationships of ABCC2 modulators using a screening approachGloria Wissel, Pavel Kudryavtsev, Leo Ghemtio, et al.
Planta Medica|February 9, 2019
Metabolism of Scoparone in Experimental Animals and HumansRisto O Juvonen, Filip Novák, Eleni Emmanouilidou, et al.
Journal of Medicinal Chemistry|May 4, 2007
Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivativesIngo Bichlmaier, Mika Kurkela, Tanmaya Joshi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 11, 2017
Identification and characterization of human UDP-glucuronosyltransferases responsible for xanthotoxol glucuronidationGuiyuan He, Johanna Troberg, Xia Lv, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 1, 2019
In vitro glucuronidation of 7-hydroxycoumarin derivatives in intestine and liver microsomes of Beagle dogsRisto O Juvonen, Aki T Heikkinen, Olli Kärkkäinen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2011
Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoformsLiangliang Zhu, Guangbo Ge, Hongbo Zhang, et al.
Pageof 25